Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • pharma-news
    • Need to reduce...

    Need to reduce dependency on API imports: Minister appeals to Pharma Companies

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2020-03-05T17:07:02+05:30  |  Updated On 5 March 2020 5:07 PM IST
    Need to reduce dependency on API imports: Minister appeals to Pharma Companies

    Generic medicines sold at dedicated Jan Aushadhi stores are cheaper by at least 50% and for some even by 90%.

    Delhi: The Union Minister for Chemicals and Fertilizers, Shri V Sadananda Gowda has said that there is no shortage of medicines in the country to deal with the outbreak of Coronavirus.

    Inaugurating India Pharma & Medical Device 2020 conference in Gandhi Nagar, Gujarat Today' Shri Gowda assured that so far, Government has been able to successfully restrict its spread in India due to strong surveillance and monitoring system. The global outbreak has not only posed an immense challenge to the pharma sector but also opened up a window of opportunity for the sector. He said the preparedness of Government, hospitals, medical institutions and the pharma sector to deal with Coronavirus in any eventuality have been strong and firmed up.

    Shri Gowda further said that there is a need to reduce our dependency on Active Pharmaceutical Ingredient (API) imports by making India self-sufficient in API manufacturing. He said that pharma companies should take a cue from this emerging situation and take steps to increase their capacity in API manufacturing.

    The Union Minister said that the potential of the pharma sector is very high. The growing population, increasing prosperity and rising awareness towards health provide a very good incentive to make further investment in this sector. If these opportunities are seized properly, the market size of the Indian Pharma Industry can reach to more than 100 Billion USD by 2025 while the Medical Devices industry can reach to 50 Billion USD by 2025. The Government has formulated schemes for development of bulk drug park and medical device park under which Union Government provides a lumpsum amount as grant in aid to the State Governments for building common facility centres in the park. We have received several proposals from States like Gujarat, Andhra Pradesh, Telangana, Tamil Nadu, Himachal Pradesh which are under active consideration in the Department.

    In developing countries, where a large section of the population may still be poor, and where out of pocket medical expenditure may be very high vis-à-vis their income, affordability of medicines is one of the prime concerns of the society as a whole. There is no doubt that the pharma industry has delivered on this account by manufacturing and supply in the country and abroad. However, a lot more is left to be achieved on this front.

    Shri Gowda said that to improve the affordability of quality generic medicines Government of India is implementing Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana (PMBJP) with the objective to realize the vision of Prime Minister, Shri Narendra Modi to make affordable medicines available to common people, especially to poor and disadvantaged. Generic medicines sold at dedicated Jan Aushadhi stores are cheaper by at least 50% and for some even by 90%. The response of people has been tremendous. Union Minister urged pharmaceutical companies to focus on R & D and launch newer drugs in the market keeping in mind affordability considerations in developing countries.

    On this occasion MoS Chemicals & Fertilizers, Shri Mansukh Mandaviya said that the pharma and medical sector can be next "sunrise" segment. The thrust of the Government is towards ease of doing business by providing long term policy stability and simplification of a regulatory mechanism that would help the pharma and medical device industry to scale new heights.

    He said that Government is committed to giving affordable healthcare to each and every citizen of India. Shri Mandaviya said that Indian Pharma sector is growing at 12% and growth of the medical device sector is at 20%. Still very good opportunities for growth. Because of Union govt.'s industry-friendly policy, low labour cost foreign industry is interested in investing in India. Gujarat Chief Minister Vijay Rupani also addressed the conference.

    Read also: IDMA warns of adverse impact of coronavirus on Indian Pharma Companies

    v-sadananda-gowdashortage-of-drugscoronaviruspm-modicovid-19API

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok